Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on the Effects of Tasimelteon for Patients with Delayed Sleep-Wake Phase Disorder
AustriaStudy on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma
BelgiumStudy on the Safety of NG004 for Patients with Acute Spinal Cord Injury
GermanyA study of low-dose interleukin-2 (aldesleukin) treatment in patients with early Alzheimer's Disease
FranceStudy on the Safety and Effectiveness of Melatonin and Ocrelizumab for Patients with Primary Progressive Multiple Sclerosis
SpainA Phase 2 Study to Evaluate Safety and Effectiveness of Omaveloxolone (RTA 408) in Patients with Friedreich's Ataxia
AustriaStudy on the Effect of Food on Selumetinib in Adolescents with Neurofibromatosis Type 1 Plexiform Neurofibromas
PolandLong-Term Safety Study of Everolimus for Patients with Tuberous Sclerosis Complex and Refractory Seizures
PolandStudy on the Safety and Effectiveness of Berubicin for Patients with Central Nervous System Lymphomas
PolandStudy on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation
BelgiumStudy on the Safety and Effectiveness of SBT101 Gene Therapy for Adults with Adrenomyeloneuropathy
The NetherlandsStudy on Tocilizumab and Steroids for Patients with Giant Cell Arteritis and Cerebrovascular Involvement
FranceThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
